Namaste Announces March 2018 Sales of C$1.24M Representing a 74% Year-on-Year Increase and Acquires 535 New Patients Representing a 142% Month-on-Month Increase

FOR IMMEDIATE RELEASE – April 6th, 2018

NAMASTE ANNOUNCES MARCH 2018 SALES OF C$1.24M REPRESENTING A 74% YEAR-ON-YEAR INCREASE AND ACQUIRES 535 NEW PATIENTS REPRESENTING A 142% MONTH-ON-MONTH INCREASE

Vancouver, British Columbia, Canada – Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE: N) (FRA: M5BQ) (OTCMKTS: NXTTF) is pleased to announce March 2018 total unaudited net revenue as reported by the Company (including shipping revenues and after discounts and refunds) were C$1,249,670, representing a 74% revenue increase in March 2018 compared with March 2017. Namaste’s management team is pleased to report that it has acquired 535 new medical cannabis patients under the Company’s wholly-owned subsidiary, Namaste MD Inc. (“NamasteMD”), representing a 142% month-over-month increase of patients. NamasteMD allows patients to consult with doctors or nurse practitioners for medical cannabis in a simple and convenient platform from the comfort of their homes. The Company anticipates seeing accelerated growth of its patient network through NamasteMD, which it believes will be a core driver of future revenue.

The table below display’s Namaste’s total gross sales by revenue channel.

[table id=6]

The table below provides detail on Namaste’s most significant revenue-driving channels including traffic, order totals, conversion rates, average order price and total revenue per channel

[table id=7]

In addition to announcing February sales, the Company is pleased to provide an update on progress with NamasteMD. During the month of March, the company acquired a total of 535 new medical cannabis patients, representing a 142% increase from February of 2018. The Company now maintains a network of 910 patients and anticipates rapid growth through new marketing initiatives and organic search traffic. NamasteMD remains a key focus for the Company is it believes that the application provides a major competitive advantage in relation to patient acquisitions versus brick and mortar clinics or doctor’s offices.

Management Commentary

Sean Dollinger, President and CEO of Namaste comments; “We are very pleased to be seeing the positive trend of monthly sales increases year-over-year. What is most exciting is our increasing rate of patient acquisition. With essentially no outside marketing we were able to quietly bring on nearly 1,000 patients by the end of the March. We are working on expanding our nurse practitioner team under NamasteMD to accommodate our anticipated growth of patients. We’re pleased to have also announced Canada’s first large-scale Prospective Study on the treatment of anxiety with Cannabis and anticipate further patient acquisition through these important studies. We believe strongly that our patients will be the key to our success, along with our strategy to provide our patients with not only the best care but also the largest and best variety of medical cannabis products. We’re proud to be innovating the industry by changing the way that patients access medical cannabis and look forward to continued growth in both the medical cannabis and hardware platforms.”

About Namaste Technologies Inc.

Namaste is the largest online retailer of medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through 24 e-commerce sites in 20 countries and with distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, Canada, and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., a Canadian based late-stage applicant for a medical cannabis sales (under the ACMPR Program) is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian medical cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.

On behalf of the Board of Directors

“Sean Dollinger”

Chief Executive Officer

Direct: +1 (786) 389 9771

Email: [email protected]

Further information on Namaste and its products can be accessed through the links below:

namastetechnologies.com

namastevapes.ca

everyonedoesit.ca

namastevaporizers.co.uk

everyonedoesit.co.uk

australianvaporizers.com.au

Forward-Looking Information

This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995. The Canadian Securities Exchange has neither reviewed nor approved the contents of this press release.